Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lung Neoplasms 18Hematologic Neoplasms 10Prostatic Neoplasms 9Colorectal Neoplasms 9Breast Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 8Carcinoma, Non-Small-Cell Lung 7Anatomic Stage I Breast Cancer AJCC v8 7Pancreatic Neoplasms 6Neoplasm Metastasis 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Neoplasms 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Carcinoma 4Breast Carcinoma In Situ 4Triple Negative Breast Neoplasms 3Multiple Myeloma 3Melanoma 3Malignant Solid Neoplasm 3Lymphoma 3Leukemia, Myeloid, Acute 3Carcinoma, Renal Cell 3Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Papillomavirus Infections 2Mouth Neoplasms 2Head and Neck Neoplasms 2

Interventions

Magnetic Resonance Spectroscopy 8Specimen Handling 7Biopsy 6X-Rays 5Phantoms, Imaging 5Temozolomide 4Nuclear Medicine Department, Hospital 4Nivolumab 4Carboplatin 4selpercatinib 3larotrectinib 3Topotecan 3Etoposide 3Cyclophosphamide 3Cisplatin 3Automobiles 3tazemetostat 2pembrolizumab 2erdafitinib 2entrectinib 2ensartinib 2cabozantinib 2Vincristine 2Surveys and Questionnaires 2Radiotherapy 2Radiosurgery 2Radiation 2Positron-Emission Tomography 2Paclitaxel 2ONC206 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Practice Guidelines as Topic × 1 year × Clear all
NCT05720624 2025-10-22

Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation

Mayo Clinic

Phase 1 Withdrawn
CNS

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡